GLP-1 medications require careful dose titration, side effect monitoring, and adjustments based on how your body responds
No clinical trials have compared these drugs specifically in women over 40, but the existing evidence highlights different strengths that matter for this age group
Additionally, GLP-1 suppresses the release of glucagon, a hormone that raises blood glucose levels, further contributing to glycaemic control
Your Found clinician determines your starting dose and titration schedule based on your health history and treatment response
Your doctor may recommend staying at the current dose longer before escalating, using supportive medications for symptom management, or determining if Zepbound is appropriate for you
Due to different but related pathways of action of CJC-1295 and Ipamorelin, scientists usually use this blend for studying growth hormone-related biological mechanisms